Triglycerides and high-density lipoprotein cholesterol are associated with insulinemia in adolescents

Salud Publica de Mexico

Volumn 48, Issue 4, 2006, Pages 293-299

  Ramírez López, Guadalupe ^a   González Villalpando, Clicerio ^b   Salmerón, Jorge ^a   González Ortiz, Manuel ^a   Valles Sánchez, Victoria ^c  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Adolescents; High density lipoprotein cholesterol; Insulin; Lipids; Mexico; Obesity; Triglycerides

Indexed keywords

HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME IMMOBILIZATION; FEMALE; HUMAN; INSULINEMIA; MALE; MEXICO; OBESITY; SEX DIFFERENCE; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 33748279282     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: 10.1590/S0036-36342006000400003     Document Type: Article

References (37)

1. Instituto Nacional de Estadística, Geografía e Informática/Secretaría de Salud. Dirección General de Información General en Salud. Base de datos de defunciones 2002. México: INEGI, 2004.
2. Berenson G, Radhakrishnamurthy B, Bao W, Srinivasan S. Does adultonset diabetes mellitus begin in childhood?: The Bogalusa Heart Study. Am J Med Sci 1995;310:Suppl 1:S77-S82.
3. Zimmet P, Collins V, Dowse G, Knight LT. Hyperinsulinemia in youth is a predictor of type 2 (non-insulin-dependent) diabetes. Diabetologia 1993;35:534-541.
4. Burke JP, Williams K, Haffner SM, González-Villalpando C, Stern MP. Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico. Diabetes Care 2001;24:1573-1578.
5. Alberti G, Zimmet P, Shaw J, Bloomgarden Z, Kaufman F, Silinik M. Type 2 diabetes in the young: the evolving epidemic. The Intenational Diabetes Federation Consensus Workshop. Diabetes Care 2004;27(7):1798-1811.
6. Duncan Glen E, Li Sierra M, Zhuo Xiao-Hua. Prevalence and trends of a metabolic syndrome phenotype among U.S. Adolescents, 1999-2000. Diabetes Care 2004;27(10):2438-2443.
7. DeFronzo R, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-194.
8. Pouliot MC, Després JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73:460-468.
9. Olfesky J, Nolan J. Insulin resistance and non-insulin-dependent diabetes mellitus: cellular and molecular mechanisms. Am J Clin Nutr 1995;61 Suppl:980S-986S.
10. Cigolini M, Seidell JC, Targher G, Deslypere JP, Ellsinger BM, Charzewska J, et al. Fasting serum insulin in relation to components of metabolic syndrome in European healthy men: The European Fat Distribution Study. Metabolism 1995;44:35-40.
11. Karhapaa P, Malkki M, Laakso M. Isolated low HDL cholesterol. An insulin-resistant state. Diabetes 1994;43:411-417.
12. Garg A. Insulin resistance in the pathogenesis of dyslipidemia. Diabetes Care 1996;19:387-389.
13. Sinaiko AR, Donahue RP, Jacobs DR Jr, Prineas RJ. Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin, and lipids in young adults. The Minneapolis Children's Blood Pressure Study. Circulation 1999;99:1471-1476.
14. Arslanian S, Kalhna S. Correlation between fatty acid and glucose metabolism. Potential explanation of insulin resistance of puberty. Diabetes 1994;43:908-914.
15. Bonora E, Targher G, Zenere MB, Saggiani F, Cacciatori V, Tosi F, et al. Relationship between fasting insulin and cardiovascular risk factors is already present in young men: the Verona Young Men Atherosclerosis Risk Factors Study. Eur J Clin Invest 1997;27:248-254.
16. Steinberger J, Moorehead C, Katch V, Rocchini AP. Relationship between insulin resistance and abnormal lipid profile in obese adolescents. J Pediatr 1995;126:690-695.
17. Moussa M, Shaltout AA, Nkansa-Dwamena D, Mourad M, Al-Sheikh N, Agha N, et al. Association of fasting insulin with serum lipids and blood pressure in Kuwaiti children. Metabolism 1998;47:420-424.
18. Chu N, Rimm E, Wang D, Liou H, Shieh S. Relationship between anthropometric variables and lipid levels among school children: The Taipei Children Heart Study. Int J Obes Relat Metab Disord 1998;22:66-72.
19. Freedman D, Serdula M, Srinivasan S, Berenson G. Relation of circumferences and skinfold thicknesses to lipid and insulin concentrations in children and adolescents: the Bogalusa Heart Study. Am J Clin Nutr 1999;69:308-317.
20. Ramírez-López G, González-Villalpando C, Sánchez-Corona J, Salmerón-Castro J, González-Ortiz M, Celis-de la Rosa A, et al. Weight, physical activity, and smoking as determinants of insulinemia in adolescents. Arch Med Res 2001;32:208-213.
21. Tietz N. Clinical guide to laboratory tests. 2nd ed. Philadelphia: WB Saunders, 1990.
22. Siedel J, Hagele E, Ziegenhorn J, Wahlefeld A. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983;29:1075-1080.
23. Bergmeyer H. Methoden enzimatischen analyse. 3rd ed. Wenheim: Verlag Chemic, 1974.
24. Greten H, Lang P, Schettler G. Lipoproteine und Herzinfarkt. Baden-Baden: Witzstrock-Verlag, 1979.
25. Burstein M, Scholnick H, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970;11:583-595.
26. Lohman T, Roche A, Martorell R. Anthropometric Standardization Reference Manual. Champaign IL: Human Kinetics Books, 1988.
27. Casillas L, Vargas L. La distribución de grasa corporal, posible factor de riesgo para la salud. Cuadernos de Nutrición 1993;16:7-15.
28. Sallis J, Buono M, Roby J, Micale F, Nelson J. Seven-day recall and other physical activity self-reports in children and adolescents. Med Sci Sports Exerc 1993;25:99-108.
29. Ainsworth BE, Haskell WL, Leon AS, Jacobs DR Jr, Montoye HJ, Sallis JF, et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993;25:71-80.
30. Hernández-Avila M, Romieu I, Parra S, Hernández-Avila J, Madrigal H, Willet W. Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Salud Publica Mex 1998;40:133-140.
31. Instituto Nacional de Salud Pública. Snut Sistema de Evaluación de Hábitos Nutricionales y Consumo de Nutrimentos. Cuernavaca Mor., México: INSP, 2003.
32. Grupo de Estudio de Insulinemia en Adolescentes. Concentración de insulina y lípidos séricos en adolescentes de preparatoria en Guadalajara, México. Salud Publica Mex 2003;45:S103-S107.
33. Jiang X, Srinivasan S, Webber L, Wattigney W, Berenson G. Association of fasting insulin level with serum lipid and lipoprotein levels in children, adolescents, and young adults: The Bogalusa Heart Study. Arch Intern Med 1995;155(2):190-196.
34. Porkka KVK, Viikari JSA, Rönnemaa T, Marniemi J, Åkerblom HK. Age and gender specific serum lipid and apolipoprotein fractiles of Finnish children and young adults. The Cardiovascular Risk in Young Finns Study. Acta Pædiatr 1994;83:838-848.
35. Webber LS, Srinivasan SR, Wattigney WA, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa Heart Study. Am J Epidemiol 1991;133:884-899.
36. Randle P, Garland P, Hales C, Newsholme E. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;I:785-789.
37. Hennes M, Shrago E, Kissebah A. Receptor and postreceptor effects of free fatty acids (FFA) on hepatocyte insulin dynamics. Int J Obes 1990;14:829-830.